| Jonathan W Sommerville, MD | |
|
308 N. Union Avenue, Havre De Grace, MD 21078 | |
| (410) 939-3121 | |
| (410) 939-8278 |
| Full Name | Jonathan W Sommerville |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 33 Years |
| Location | 308 N. Union Avenue, Havre De Grace, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841273521 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | D0061484 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Umd Upper Chesapeake Medical Center | Bel air, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Susquehanna Ob-gyn Pa | 9335129766 | 12 |
News Archive
Rensselaer Polytechnic Institute Professor Richard Radke is leading a new $1.4 million study to develop novel computer automation techniques that could reduce the prep time of a promising cancer-treatment technology from several hours to a few minutes.
A plaster which sticks to the inside of your mouth is revolutionising the treatment of painful recurring ulcers.
Laws that end smoking at work and other public places result in significantly fewer hospitalizations for heart attacks, strokes, asthma and other respiratory conditions, a new UCSF analysis has found.
Teva Pharmaceutical Industries Ltd., announced today that the European Commission has granted marketing authorization for DuoResp Spiromax for the treatment of patients with asthma and chronic obstructive pulmonary disease (COPD) where the use of a combination of an inhaled corticosteroid and long-acting beta2-adrenoceptor agonist is appropriate.
› Verified 8 days ago
| Entity Name | Susquehanna Ob-gyn Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104818871 PECOS PAC ID: 9335129766 Enrollment ID: O20040724000337 |
News Archive
Rensselaer Polytechnic Institute Professor Richard Radke is leading a new $1.4 million study to develop novel computer automation techniques that could reduce the prep time of a promising cancer-treatment technology from several hours to a few minutes.
A plaster which sticks to the inside of your mouth is revolutionising the treatment of painful recurring ulcers.
Laws that end smoking at work and other public places result in significantly fewer hospitalizations for heart attacks, strokes, asthma and other respiratory conditions, a new UCSF analysis has found.
Teva Pharmaceutical Industries Ltd., announced today that the European Commission has granted marketing authorization for DuoResp Spiromax for the treatment of patients with asthma and chronic obstructive pulmonary disease (COPD) where the use of a combination of an inhaled corticosteroid and long-acting beta2-adrenoceptor agonist is appropriate.
› Verified 8 days ago
| Entity Name | Privia Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013042480 PECOS PAC ID: 4385682061 Enrollment ID: O20140522000040 |
News Archive
Rensselaer Polytechnic Institute Professor Richard Radke is leading a new $1.4 million study to develop novel computer automation techniques that could reduce the prep time of a promising cancer-treatment technology from several hours to a few minutes.
A plaster which sticks to the inside of your mouth is revolutionising the treatment of painful recurring ulcers.
Laws that end smoking at work and other public places result in significantly fewer hospitalizations for heart attacks, strokes, asthma and other respiratory conditions, a new UCSF analysis has found.
Teva Pharmaceutical Industries Ltd., announced today that the European Commission has granted marketing authorization for DuoResp Spiromax for the treatment of patients with asthma and chronic obstructive pulmonary disease (COPD) where the use of a combination of an inhaled corticosteroid and long-acting beta2-adrenoceptor agonist is appropriate.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jonathan W Sommerville, MD P.o. Box 420, Havre De Grace, MD 21078 Ph: (410) 939-3121 | Jonathan W Sommerville, MD 308 N. Union Avenue, Havre De Grace, MD 21078 Ph: (410) 939-3121 |
News Archive
Rensselaer Polytechnic Institute Professor Richard Radke is leading a new $1.4 million study to develop novel computer automation techniques that could reduce the prep time of a promising cancer-treatment technology from several hours to a few minutes.
A plaster which sticks to the inside of your mouth is revolutionising the treatment of painful recurring ulcers.
Laws that end smoking at work and other public places result in significantly fewer hospitalizations for heart attacks, strokes, asthma and other respiratory conditions, a new UCSF analysis has found.
Teva Pharmaceutical Industries Ltd., announced today that the European Commission has granted marketing authorization for DuoResp Spiromax for the treatment of patients with asthma and chronic obstructive pulmonary disease (COPD) where the use of a combination of an inhaled corticosteroid and long-acting beta2-adrenoceptor agonist is appropriate.
› Verified 8 days ago
Mrs. Linda Daniels Barakat, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 308 N Union Ave, Havre De Grace, MD 21078 Phone: 410-939-3121 |